Related references
Note: Only part of the references are listed.Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis
Antonio Diez-Ruiz et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease
G. Fiorino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M. Allez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
M. J. Harrison et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Differences in binding and effector functions between classes of TNF antagonists
Taruna Arora et al.
CYTOKINE (2009)
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
C. Coquerelle et al.
GUT (2009)
Blocking CD27-CD70 Costimulatory Pathway Suppresses Experimental Colitis
Monika Manocha et al.
JOURNAL OF IMMUNOLOGY (2009)
Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
Yasunori Kageyama et al.
MODERN RHEUMATOLOGY (2009)
Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study
Damien Fouache et al.
RHEUMATOLOGY (2009)
The role of TNF superfamily members in T-cell function and diseases
Michael Croft
NATURE REVIEWS IMMUNOLOGY (2009)
Blockade of NKG2D signaling prevents the development of murine CD4(+) T cell-mediated colitis
Y. Ito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
V. Gerloni et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J. Schmitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation
Hidetoshi Takedatsu et al.
GASTROENTEROLOGY (2008)
A crucial role for HVEM and BTLA in preventing intestinal inflammation
Marcos W. Steinberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
Clare A. Notley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor at agents
Andrew Nesbitt et al.
INFLAMMATORY BOWEL DISEASES (2007)
Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion
Zhanju Liu et al.
JOURNAL OF AUTOIMMUNITY (2007)
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions
Matthieu Allez et al.
GASTROENTEROLOGY (2007)
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents
J. Braun et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice
Stine Kjellev et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis
Yasunori Kageyama et al.
CLINICAL RHEUMATOLOGY (2007)
Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease
Masayuki Saruta et al.
JOURNAL OF IMMUNOLOGY (2007)
BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation
Heather A. Arnett et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production
Elena Friedmann et al.
NATURE CELL BIOLOGY (2006)
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4+ T cell-mediated inflammatory colitis
P Maerten et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease
J Lee et al.
IMMUNOLOGY LETTERS (2005)
Lymphtoxin β receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling
MM An et al.
PHARMACOLOGICAL RESEARCH (2005)
The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease
J Wang et al.
JOURNAL OF IMMUNOLOGY (2005)
Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-γ production by peripheral blood and mucosal CCR9+ T lymphocytes'
KA Papadakis et al.
JOURNAL OF IMMUNOLOGY (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept
C Shen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-α
H Mitoma et al.
GASTROENTEROLOGY (2005)
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease
T Sato et al.
GASTROENTEROLOGY (2004)
Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis
YP de Jong et al.
INTERNATIONAL IMMUNOLOGY (2004)
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
G Eissner et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Regulatory T cells: Peace keepers in the gut
M Allez et al.
INFLAMMATORY BOWEL DISEASES (2004)
Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form
N Corazza et al.
GASTROENTEROLOGY (2004)
Potential role for TLlX the new TNF-family member and potent costimulator of IFN-γ, in mucosal inflammation
JL Prehn et al.
CLINICAL IMMUNOLOGY (2004)
The CD40/CD40L costimulatory pathway in inflammatory bowel disease
S Danese et al.
GUT (2004)
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease
A Di Sabatino et al.
GUT (2004)
Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease
G Bamias et al.
JOURNAL OF IMMUNOLOGY (2003)
Blockade of B7-H1 suppresses intestinal inflammation the development of chronic
T Kanai et al.
JOURNAL OF IMMUNOLOGY (2003)
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis
JP Utz et al.
CHEST (2003)
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease
JMH Van Den Brande et al.
GASTROENTEROLOGY (2003)
Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis
T Totsuka et al.
GASTROENTEROLOGY (2003)
OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice
F Obermeier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
TNF receptor subtype signalling: Differences and cellular consequences
DJ MacEwan
CELLULAR SIGNALLING (2002)
Binding and functional comparisons of two types of tumor necrosis factor antagonists
B Scallon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction
RB Shaikh et al.
JOURNAL OF IMMUNOLOGY (2001)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
A Lügering et al.
GASTROENTEROLOGY (2001)
Type II tumour necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAR pathways
OJ Jupp et al.
BIOCHEMICAL JOURNAL (2001)
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α
PH Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The essential role of MEKK3 in TNF-induced NF-κB activation
JH Yang et al.
NATURE IMMUNOLOGY (2001)
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice
V Malmström et al.
JOURNAL OF IMMUNOLOGY (2001)
Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions
ZJ Liu et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
